068270:KRX
Celltrion Inc
â‚©193,950.00
arrow_downward
-0.03%(-50.00) 1D
Oct 19, 12:59:07 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 068270...
Open
â‚©193,900
High
â‚©195,400
Low
â‚©189,500
Mkt. cap
45.10T
Avg. vol.
413.96K
Volume
312.96K
Dividend
0.37%
Quarterly dividend
â‚©179
Ex-dividend date
Dec 29, 2025
P/E ratio
28.35
52-wk high
â‚©239,047
52-wk low
â‚©158,500
EPS
â‚©6,842
Shares outstanding
232.62M
No. of employees
3K
Open
â‚©193,900
High
â‚©195,400
Low
â‚©189,500
Mkt. cap
45.10T
Avg. vol.
413.96K
Volume
312.96K
Dividend
0.37%
Quarterly dividend
â‚©179
Ex-dividend date
Dec 29, 2025
P/E ratio
28.35
52-wk high
â‚©239,047
52-wk low
â‚©158,500
EPS
â‚©6,842
Shares outstanding
232.62M
No. of employees
3K
News stories
From web sources and news partners
BigGo Finance
·
3 days ago
Pharma and Biotech Stocks Surge in Tandem... Celltrion Up 6%, LigaChem Biosciences Up 8%
Profile
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
About Celltrion Inc